Month: October 2021

VistaGen Therapeutics Reports New Preclinical Mechanism of Action Data Supporting PH94B’s Potential Anti-Anxiety Activity via Peripheral Nasal Neurons without Entry into the Brain

Preclinical study of intranasal radiolabeled PH94B in laboratory rats further differentiates PH94B’s mechanism of action…

Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from Hercules Capital

WATERTOWN, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX), today announced…

VBL Therapeutics Announces Appointment of Sam Backenroth as Chief Financial Officer and Establishes Operations in the United States

Amos Ron to Retire as CFO and Will Continue to Serve as Corporate Secretary, Advisor…

Enlivex Receives Notice of Allowance for Israeli Patent Application Covering Allocetra Derived from Pooled Donor Cells

Nes-Ziona, Israel, Oct. 05, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…

Coherus Announces Positive Results of UDENYCA® On-Body Injector Clinical Trial

– UDENYCA® On-Body Injector (OBI) Achieved Both Pharmacokinetic and Pharmacodynamic Bioequivalence in Randomized Clinical Trial…

Akero Therapeutics to Present at the H.C. Wainwright 5th Annual NASH Investor Conference

SOUTH SAN FRANCISCO, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic…

Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation Officer

Industry veteran with decades of experience in company formation, scientific research, and drug development to…

Quotient Limited Announces Appointment of Chief Commercial Officer

JERSEY, Channel Islands, Oct. 05, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics…

Statera Biopharma Announces CEO Mike Handley to Speak During Virtual B & T Cell-Mediated Autoimmune Disease Drug Development Summit

FORT COLLINS, Colo., Oct. 05, 2021 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (Nasdaq: STAB), a…

Nephros to Present at the LD Micro Main Event

SOUTH ORANGE, NJ, Oct. 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc. (Nasdaq: NEPH), a leading…

Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson

Research to take place at Johns Hopkins, New York University and University of Alabama Birmingham…

Harpoon Therapeutics to Present Preclinical Data on its TriTAC-XR Platform at the 36th Annual Meeting of the Society for Immunotherapy of Cancer

SOUTH SAN FRANCISCO, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP),…

Humacyte Leadership to Present at Seven Scientific and Industry Events in October

DURHAM, N.C., Oct. 05, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…

TScan Therapeutics Appoints Heather Savelle as Vice President, Investor Relations

WALTHAM, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a biopharmaceutical…

Finch Therapeutics Appoints Samuel Allen Hamood to its Board of Directors

SOMERVILLE, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…

IpiNovyx Bio Closes $10 Million Seed Financing to Advance Best-in-Class Immunoproteasome Inhibitors Toward First-in-Human Clinical Studies

Participating Investors include Viva BioInnovator, Eli Lilly and Company, Opaleye Management, Orange Grove Bio and…

Month: October 2021

VistaGen Therapeutics Reports New Preclinical Mechanism of Action Data Supporting PH94B’s Potential Anti-Anxiety Activity via Peripheral Nasal Neurons without Entry into the Brain

Eloxx Pharmaceuticals Secures Debt Facility of Up to $30 Million from Hercules Capital

VBL Therapeutics Announces Appointment of Sam Backenroth as Chief Financial Officer and Establishes Operations in the United States

Enlivex Receives Notice of Allowance for Israeli Patent Application Covering Allocetra Derived from Pooled Donor Cells

Coherus Announces Positive Results of UDENYCA® On-Body Injector Clinical Trial

Akero Therapeutics to Present at the H.C. Wainwright 5th Annual NASH Investor Conference

Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation Officer

Quotient Limited Announces Appointment of Chief Commercial Officer

Statera Biopharma Announces CEO Mike Handley to Speak During Virtual B & T Cell-Mediated Autoimmune Disease Drug Development Summit

Nephros to Present at the LD Micro Main Event

Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson

Harpoon Therapeutics to Present Preclinical Data on its TriTAC-XR Platform at the 36th Annual Meeting of the Society for Immunotherapy of Cancer

Humacyte Leadership to Present at Seven Scientific and Industry Events in October

TScan Therapeutics Appoints Heather Savelle as Vice President, Investor Relations

Finch Therapeutics Appoints Samuel Allen Hamood to its Board of Directors

IpiNovyx Bio Closes $10 Million Seed Financing to Advance Best-in-Class Immunoproteasome Inhibitors Toward First-in-Human Clinical Studies

Baudax Bio to Present at the NobleCon Pain Management Investor Forum

Aleafia Health Builds on Adult-use Momentum with Retailer Harvest Party

UPDATE – Todos Medical Announces October Conference Calendar

Notified Launches MarketPlace to Drive Community Engagement for Events Industry

You may have missed

Singapore’s most anticipated skyhigh destination C.O.T.U officially opens in iconic Marina Bay this holiday season

Nakornthon Hospital PCL (SET: NKT) in First Trading Day on SET

Feel the Magic of Snowfall at Spritzer EcoPark’s Festive Wonder Carnival 2024

Seamless HDB Renovations: How 2 Design Combines Expertise with In-House Solutions

Summit Group Responds to White Paper Citing Governance Issues in Bangladesh’s Power and Energy Sector